Sandra L. Wegert

Array ( [id] => 326767 [patent_doc_number] => 07514538 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-04-07 [patent_title] => 'Compositions and methods for the diagnosis and treatment of tumor' [patent_app_type] => utility [patent_app_number] => 12/031612 [patent_app_country] => US [patent_app_date] => 2008-02-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 52553 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 15 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/514/07514538.pdf [firstpage_image] =>[orig_patent_app_number] => 12031612 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4823133 [patent_doc_number] => 20080227745 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-09-18 [patent_title] => 'Methods and compositions for soluble CPG15' [patent_app_type] => utility [patent_app_number] => 12/069071 [patent_app_country] => US [patent_app_date] => 2008-02-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 21156 [patent_no_of_claims] => 33 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0227/20080227745.pdf [firstpage_image] =>[orig_patent_app_number] => 12069071 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4664859 [patent_doc_number] => 20080255766 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-10-16 [patent_title] => 'Methods and kits for the diagnosis of sickle cell' [patent_app_type] => utility [patent_app_number] => 12/068518 [patent_app_country] => US [patent_app_date] => 2008-02-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 6177 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0255/20080255766.pdf [firstpage_image] =>[orig_patent_app_number] => 12068518 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4807461 [patent_doc_number] => 20080171039 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-07-17 [patent_title] => 'Compositions Against Cancer Antigen Liv-1 and Uses Thereof' [patent_app_type] => utility [patent_app_number] => 11/962593 [patent_app_country] => US [patent_app_date] => 2007-12-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 17999 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0171/20080171039.pdf [firstpage_image] =>[orig_patent_app_number] => 11962593 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4764628 [patent_doc_number] => 20080175839 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-07-24 [patent_title] => 'Compositions Against Cancer Antigen LIV-1 and Uses Thereof' [patent_app_type] => utility [patent_app_number] => 11/963641 [patent_app_country] => US [patent_app_date] => 2007-12-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 18130 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0175/20080175839.pdf [firstpage_image] =>[orig_patent_app_number] => 11963641 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4663575 [patent_doc_number] => 20080254482 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-10-16 [patent_title] => 'AUTOIMMUNE DISEASE BIOMARKERS' [patent_app_type] => utility [patent_app_number] => 11/944254 [patent_app_country] => US [patent_app_date] => 2007-11-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 44510 [patent_no_of_claims] => 34 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0254/20080254482.pdf [firstpage_image] =>[orig_patent_app_number] => 11944254 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4676841 [patent_doc_number] => 20080214472 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-09-04 [patent_title] => 'Small Peptides And Methods For Treatment Of Arthritis' [patent_app_type] => utility [patent_app_number] => 11/942160 [patent_app_country] => US [patent_app_date] => 2007-11-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 16 [patent_no_of_words] => 13113 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0214/20080214472.pdf [firstpage_image] =>[orig_patent_app_number] => 11942160 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6601343 [patent_doc_number] => 20100048869 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-02-25 [patent_title] => 'AGENT COMPRISING G-CSF FOR PREVENTION AND TREATMENT OF DIABETIC PERIPHERAL NEUROPATHY' [patent_app_type] => utility [patent_app_number] => 12/447798 [patent_app_country] => US [patent_app_date] => 2007-10-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 4203 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0048/20100048869.pdf [firstpage_image] =>[orig_patent_app_number] => 12447798 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 91704 [patent_doc_number] => 07732147 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-06-08 [patent_title] => 'Neurotransmission disorders' [patent_app_type] => utility [patent_app_number] => 11/895793 [patent_app_country] => US [patent_app_date] => 2007-08-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 8 [patent_no_of_words] => 6305 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 41 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/732/07732147.pdf [firstpage_image] =>[orig_patent_app_number] => 11895793 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4894192 [patent_doc_number] => 20080103291 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-05-01 [patent_title] => 'DNA MOLECULES ENCODING LIGAND GATED ION CHANNELS FROM DERMACENTOR VARIABILIS' [patent_app_type] => utility [patent_app_number] => 11/840519 [patent_app_country] => US [patent_app_date] => 2007-08-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 18 [patent_no_of_words] => 21079 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0103/20080103291.pdf [firstpage_image] =>[orig_patent_app_number] => 11840519 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 177732 [patent_doc_number] => 07655440 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-02-02 [patent_title] => 'DNA molecules encoding ligand gated ion channels from Dermacentor variabilis' [patent_app_type] => utility [patent_app_number] => 11/840542 [patent_app_country] => US [patent_app_date] => 2007-08-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 17 [patent_no_of_words] => 21105 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 27 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/655/07655440.pdf [firstpage_image] =>[orig_patent_app_number] => 11840542 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5165267 [patent_doc_number] => 20070286851 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-12-13 [patent_title] => 'Method of Identifying Modulators of NOGO-Functions' [patent_app_type] => utility [patent_app_number] => 11/836887 [patent_app_country] => US [patent_app_date] => 2007-08-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 8854 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0286/20070286851.pdf [firstpage_image] =>[orig_patent_app_number] => 11836887 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 318826 [patent_doc_number] => 07521536 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-04-21 [patent_title] => 'Glutamate transporter associated protein' [patent_app_type] => utility [patent_app_number] => 11/888900 [patent_app_country] => US [patent_app_date] => 2007-08-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 26 [patent_figures_cnt] => 39 [patent_no_of_words] => 27070 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 17 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/521/07521536.pdf [firstpage_image] =>[orig_patent_app_number] => 11888900 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4827313 [patent_doc_number] => 20080125580 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-05-29 [patent_title] => 'Refolding of Recombinant Proteins' [patent_app_type] => utility [patent_app_number] => 11/777997 [patent_app_country] => US [patent_app_date] => 2007-07-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 16314 [patent_no_of_claims] => 32 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0125/20080125580.pdf [firstpage_image] =>[orig_patent_app_number] => 11777997 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4909220 [patent_doc_number] => 20080019986 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-01-24 [patent_title] => 'Methods of inhibiting binding of beta-sheet fibril to rage and consequences thereof' [patent_app_type] => utility [patent_app_number] => 11/805164 [patent_app_country] => US [patent_app_date] => 2007-05-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 22 [patent_figures_cnt] => 22 [patent_no_of_words] => 25330 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0019/20080019986.pdf [firstpage_image] =>[orig_patent_app_number] => 11805164 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8802513 [patent_doc_number] => 08440788 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-05-14 [patent_title] => 'N-terminal VDAC variants and uses thereof' [patent_app_type] => utility [patent_app_number] => 12/296239 [patent_app_country] => US [patent_app_date] => 2007-04-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 14 [patent_no_of_words] => 16207 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 90 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12296239 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4977224 [patent_doc_number] => 20070218456 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-09-20 [patent_title] => 'CELLULAR ASSAYS FOR SIGNALING RECEPTORS' [patent_app_type] => utility [patent_app_number] => 11/672841 [patent_app_country] => US [patent_app_date] => 2007-02-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 29 [patent_figures_cnt] => 29 [patent_no_of_words] => 44210 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0218/20070218456.pdf [firstpage_image] =>[orig_patent_app_number] => 11672841 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4798022 [patent_doc_number] => 20080009608 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-01-10 [patent_title] => 'Sitosterolemia susceptibility gene (SSG): compositions and methods of use' [patent_app_type] => utility [patent_app_number] => 11/647126 [patent_app_country] => US [patent_app_date] => 2006-12-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 20 [patent_figures_cnt] => 20 [patent_no_of_words] => 28836 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0009/20080009608.pdf [firstpage_image] =>[orig_patent_app_number] => 11647126 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4976824 [patent_doc_number] => 20070218055 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-09-20 [patent_title] => 'Ferroportin1 nucleic acids and proteins' [patent_app_type] => utility [patent_app_number] => 11/641589 [patent_app_country] => US [patent_app_date] => 2006-12-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 21093 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0218/20070218055.pdf [firstpage_image] =>[orig_patent_app_number] => 11641589 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5130743 [patent_doc_number] => 20070207140 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-09-06 [patent_title] => 'Purified and isolated potassium-chloride cotransporter nucleic acids and polypeptides and therapeutic and screening methods using same' [patent_app_type] => utility [patent_app_number] => 11/637625 [patent_app_country] => US [patent_app_date] => 2006-12-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 43 [patent_figures_cnt] => 43 [patent_no_of_words] => 50203 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0207/20070207140.pdf [firstpage_image] =>[orig_patent_app_number] => 11637625 [rel_patent_id] =>[rel_patent_doc_number] =>)